86
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Clear differences in cerebrospinal fluid proteome between women with chronic widespread pain and healthy women – a multivariate explorative cross-sectional study

, , &
Pages 575-590 | Published online: 13 Mar 2017

References

  • CroftPBurtJSchollumJThomasEMacfarlaneGSilmanAMore pain, more tender points: is fibromyalgia just one end of a continuous spectrum?Ann Rheum Dis19965574824858774169
  • Grimby-EkmanAGerdleBBjörkJLarssonBComorbidities, intensity, frequency and duration of pain, daily functioning and health care seeking in local, regional, and widespread pain – a descriptive population-based survey (SwePain)BMC Musculoskelet Disord20151616526205125
  • PeolssonMBorsboBGerdleBGeneralized pain is associated with more negative consequences than local or regional pain: a study of chronic whiplash-associated disordersJ Rehabil Med200739326026817468796
  • MayerTGTownsBLNeblettRTheodoreBRGatchelRJChronic widespread pain in patients with occupational spinal disorders: prevalence, psychiatric comorbidity, and association with outcomesSpine (Phila Pa 1976)200833171889189718670343
  • SchaeferCChandranAHufstaderMThe comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United StatesHealth Qual Life Outcomes201197121859448
  • KamaleriYNatvigBIhlebaekCMBenthJSBruusgaardDNumber of pain sites is associated with demographic, lifestyle, and health-related factors in the general populationEur J Pain200812674274818160318
  • GerdleBBjörkJCösterLHenrikssonKHenrikssonCBengtssonAPrevalence of widespread pain and associations with work status: a population studyBMC Musculoskelet Disord2008910218627605
  • MansfieldKESimJJordanJLJordanKPA systematic review and meta-analysis of the prevalence of chronic widespread pain in the general populationPain20161571556426270591
  • ButlerSLandmarkTGletteMBorchgrevinkPWoodhouseAChronic widespread pain-the need for a standard definitionPain2016157354154326574821
  • JensenKBLoitoileRKosekEPatients with fibromyalgia display less functional connectivity in the brain’s pain inhibitory networkMol Pain201283222537768
  • NijsJKosekEVan OosterwijckJMeeusMDysfunctional endogenous analgesia during exercise in patients with chronic pain: to exercise or not to exercise?Pain Physician2012153 supplES205ES21322786458
  • PeterselDLDrorVCheungRCentral amplification and fibromyalgia: disorder of pain processingJ Neurosci Res2011891293420936697
  • HeinricheraMMTavarescILeithJLLumbeBMDescending control of nociception: specificity, recruitment and plasticityBrain Res Rev200960121422519146877
  • AdlerGKGeenenRHypothalamic-pituitary-adrenal and autonomic nervous system functioning in fibromyalgiaRheum Dis Clin North Am2005311187202xi15639063
  • DesseinPHShiptonEAStanwixAEJoffeBINeuroendocrine deficiency-mediated development and persistence of pain in fibromyalgia: a promising paradigm?Pain200086321321510812250
  • BradleyLAPathophysiology of fibromyalgiaAm J Med200912212 supplS22S30
  • SmithHHarrisRClauwDFibromyalgia: an afferent processing disorder leading to a complex pain generalized syndromePain Physician2011142E217E24521412381
  • GerdleBLemmingDKristiansenJLarssonBPeolssonMRosendalLBiochemical alterations in the trapezius muscle of patients with chronic whiplash associated disorders (WAD) – a microdialysis studyEur J Pain2008121829317459742
  • ÜçeylerNZellerDKahnAKSmall fibre pathology in patients with fibromyalgia syndromeBrain2013136pt 61857186723474848
  • OaklanderALHerzogZDDownsHMKleinMMObjective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgiaPain2013154112310231623748113
  • SerraJColladoASolàRHyperexcitable C nociceptors in fibromyalgiaAnn Neurol201475219620824243538
  • BennettRMEmerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgiaMayo Clin Proc199974438539810221469
  • StaudRThe role of peripheral input for chronic pain syndromes like fibromyalgia syndromeJ Musculoskelet Pain2008161–26774
  • SchneiderGMSmithADHooperAMinimizing the source of nociception and its concurrent effect on sensory hypersensitivity: an exploratory study in chronic whiplash patientsBMC Musculoskelet Disord2010112920144214
  • StaudRNagelSRobinsonMEPriceDDEnhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled studyPain20091451–29610419540671
  • Herren-GerberRWeissSArendt-NielsenLModulation of central hypersensitivity by nociceptive input in chronic pain after whiplash injuryPain Med20045436637615563322
  • StaudRRobinsonMEWeylEEPriceDDPain variability in fibromyalgia is related to activity and rest: role of peripheral tissue impulse inputJ Pain201011121376138320451465
  • KosekEEkholmJHanssonPModulation of pressure pain thresholds during and following isometric contraction in patients with fibromyalgia and in healthy controlsPain19966434154238783304
  • MannesAJMartinBMYangHYCystatin C as a cerebrospinal fluid biomarker for pain in humansPain2003102325125612670666
  • RomeoMJEspinaVLowenthalMEspinaBHPetricoinEF3rdLiottaLACSF proteome: a protein repository for potential biomarker identificationExpert Rev Proteomics200521577015966853
  • OrtegaEGarcíaJJBoteMEExercise in fibromyalgia and related inflammatory disorders: known effects and unknown chancesExerc Immunol Rev200915426519957871
  • ShevchenkoGKonzerAMusunuriSBergquistJNeuroproteomics tools in clinical practiceBiochim Biophys Acta20151854770571725680928
  • JohansonCEDuncanJA3rdKlingePMBrinkerTStopaEGSilver-bergGDMultiplicity of cerebrospinal fluid functions: new challenges in health and diseaseCerebrospinal Fluid Res200851018479516
  • RussellIJOrrMDLittmanBElevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndromeArthritis Rheum19943711159316017526868
  • VaerøyHHelleRFørreOKåssETereniusLElevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosisPain198832121262448729
  • BjurstromMFGironSEGriffisCACerebrospinal fluid cytokines and neurotrophic factors in human chronic pain populations: a comprehensive reviewPain Pract201616218320325353056
  • KalsoEBiomarkers for painPain2004107319920114736580
  • WheelockAMWheelockCETrials and tribulations of ’omics data analysis: assessing quality of SIMCA-based multivariate models using examples from pulmonary medicineMol Biosyst20139112589259623999822
  • GörgADrewsOLückCWeilandFWeissW2-DE with IPGsElectrophoresis200930suppl 1S122S13219441019
  • LiuXDZengBFXuJGZhuHBXiaQCProteomic analysis of the cerebrospinal fluid of patients with lumbar disk herniationProteomics2006631019102816372267
  • ContiARicchiutoPIannacconeSPigment epithelium-derived factor is differentially expressed in peripheral neuropathiesProteomics20055174558456716196102
  • LuJKatanoTNishimuraWProteomic analysis of cerebrospinal fluid before and after intrathecal injection of steroid into patients with postherpetic painProteomics20121219–203105311222936653
  • PattiniLMazzaraSContiAIannacconeSCeruttiSAlessioMAn integrated strategy in two-dimensional electrophoresis analysis able to identify discriminants between different clinical conditionsExp Biol Med (Maywood)2008233448349118367638
  • CannistraciCVRavasiTMontevecchiFMIdekerTAlessioMNonlinear dimension reduction and clustering by Minimum Curvilinearity unfold neuropathic pain and tissue embryological classesBioinformatics20102618i531i53920823318
  • BäckrydEGhafouriBCarlssonAKOlaussonPGerdleBMultivariate proteomic analysis of the cerebrospinal fluid of patients with peripheral neuropathic pain and healthy controls – a hypothesis-generating pilot studyJ Pain Res2015832133326170714
  • WolfeFSmytheHAYunusMBThe American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria CommitteeArthritis Rheum19903321601722306288
  • SjörsALarssonBPerssonALGerdleBAn increased response to experimental muscle pain is related to psychological status in women with chronic non-traumatic neck-shoulder painBMC Musculoskelet Disord20111223021992460
  • BjellandIDahlAAHaugTTNeckelmannDThe validity of the Hospital Anxiety and Depression Scale. An updated literature reviewJ Psychosom Res2002522697711832252
  • ZigmondASSnaithRPThe hospital anxiety and depression scaleActa Psychiatr Scand19836763613706880820
  • SullivanMJLBishopSRPivikJThe pain catastrophizing scale: development and validationPsychol Assess19957524532
  • OsmanABarriosFXGutierrezPMKopperBAMerrifieldTGrittmannLThe Pain Catastrophizing Scale: further psychometric evaluation with adult samplesJ Behav Med200023435136510984864
  • ScottWWidemanTHSullivanMJClinically meaningful scores on pain catastrophizing before and after multidisciplinary rehabilitation: a prospective study of individuals with subacute pain after whiplash injuryClin J Pain201430318319023552561
  • BurckhardtCSArchenholtzBBjelleAMeasuring the quality of life of women with rheumatoid arthritis or systemic lupus erythematosus: a Swedish version of the Quality of Life Scale (QOLS)Scand J Rheumatol19922141901951529286
  • OsmanIGaillardOMeilletDA sensitive time-resolved immunofluorometric assay for the measurement of apolipoprotein B in cerebrospinal fluid. Application to multiple sclerosis and other neurological diseasesEur J Clin Chem Clin Biochem199533153587756441
  • OlaussonPGerdleBGhafouriNSjöströmDBlixtEGhafouriBProtein alterations in women with chronic widespread pain – an explorative proteomic study of the trapezius muscleSci Rep201551189426150212
  • BradfordMMA rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnal Biochem197672248254942051
  • RosendalLLarssonBKristiansenJIncrease in muscle nociceptive substances and anaerobic metabolism in patients with trapezius myalgia: microdialysis in rest and during exercisePain2004112332433415561388
  • ErikssonLByrneTJohanssonETryggJVikströmCMulti- and Megavariate Data Analysis: Basic Principles and Applications3rd revised edMalmöMKS Umetrics AB2013
  • ScaliaPHeartEComaiLVigneriRSungCKRegulation of the Akt/Glycogen synthase kinase-3 axis by insulin-like growth factor-II via activation of the human insulin receptor isoform-AJ Cell Biochem200182461061811500939
  • HughesAMohanasundaramDKiretaSJessupCFDrogemullerCJCoatesPTInsulin-Like growth factor-II (IGF-II) prevents proinflammatory cytokine-induced apoptosis and significantly improves islet survival after transplantationTransplantation201395567167823364485
  • HughesARojas-CanalesDDrogemullerCVoelckerNHGreySTCoatesPTIGF2: an endocrine hormone to improve islet transplant survivalJ Endocrinol20142212R41R4824883437
  • YehCCSunHLHuangCJLong-term anti-allodynic effect of immediate pulsed radiofrequency modulation through down-regulation of insulin-like growth factor 2 in a neuropathic pain modelInt J Mol Sci20151611271562717026580597
  • ChenXKongXZhangZAlpha-2-macroglobulin as a radio-protective agent: a reviewChin J Cancer Res201426561162125400428
  • RehmanAAAhsanHKhanFHalpha-2-Macroglobulin: a physiological guardianJ Cell Physiol201322881665167523086799
  • BhamraMSAshtonNJFinding a pathological diagnosis for Alzheimer’s disease: are inflammatory molecules the answer?Electrophoresis201233243598360723161254
  • KanohYOhtaniHLevels of interleukin-6, CRP and alpha 2 macroglobulin in cerebrospinal fluid (CSF) and serum as indicator of blood-CSF barrier damageBiochem Mol Biol Int19974322692789350334
  • HayesLNSeveranceEGLeekJTInflammatory molecular signature associated with infectious agents in psychosisSchizophr Bull201440596397224743863
  • DitzenCTangNJastorffAMCerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiologyNeuropsychopharmacology20123741013102522169944
  • Diaz-RamosARoig-BorrellasAGarcía-MeleroALópez-AlemanyRalpha-Enolase, a multifunctional protein: its role on pathophysiological situationsJ Biomed Biotechnol2012201215679523118496
  • RoydsJADavies-JonesGALewtasNATimperleyWRTaylorCBEnolase isoenzymes in the cerebrospinal fluid of patients with diseases of the nervous systemJ Neurol Neurosurg Psychiatry19834611103110366317805
  • OhashiKHaraMKawaiRCervical discs are most susceptible to beta 2-microglobulin amyloid deposition in the vertebral columnKidney Int1992416164616521501421
  • SvatoňováJBořeckáKAdamPLánskáVBeta2-microglobulin as a diagnostic marker in cerebrospinal fluid: a follow-up studyDis Markers2014201449540224895473
  • AnckarsäterRVasicNJidéusLCerebrospinal fluid protein reactions during non-neurological surgeryActa Neurol Scand2007115425425917376123
  • BuchwaldDWenerMHPearlmanTKithPMarkers of inflammation and immune activation in chronic fatigue and chronic fatigue syndromeJ Rheumatol19972423723769034999
  • KepplingerBBaranHKainzAFerraz-LeiteHNewcombeJKalinaPAge-related increase of kynurenic acid in human cerebrospinal fluid – IgG and beta2-microglobulin changesNeurosignals200514312613516088227
  • ZellnerMVeitingerMUmlaufEThe role of proteomics in dementia and Alzheimer’s diseaseActa Neuropathol2009118118119519259691
  • MatejčíkováZMarešJPřikrylová VranováHCerebrospinal fluid inflammatory markers in patients with multiple sclerosis: a pilot studyJ Neural Transm (Vienna)2015122227327724894698
  • CarrieriPBIndacoAMaiorinoACerebrospinal fluid beta-2-microglobulin in multiple sclerosis and AIDS dementia complexNeurol Res19921432822831355285
  • SladkovaVMarešJLubenovaBDegenerative and inflammatory markers in the cerebrospinal fluid of multiple sclerosis patients with relapsing-remitting course of disease and after clinical isolated syndromeNeurol Res201133441542021535941
  • HerbertJWilcoxJNPhamKTTransthyretin: a choroid plexus-specific transport protein in human brain. The 1986 S. Weir Mitchell awardNeurology19863679009113714052
  • ChanoineJPAlexSFangSLRole of transthyretin in the transport of thyroxine from the blood to the choroid plexus, the cerebrospinal fluid, and the brainEndocrinology199213029339381733735
  • ChanoineJPBravermanLEThe role of transthyretin in the transport of thyroid hormone to cerebrospinal fluid and brainActa Med Austriaca199219suppl 12528
  • RiallandPOtisCde CourvalMLAssessing experimental visceral pain in dairy cattle: a pilot, prospective, blinded, randomized, and controlled study focusing on spinal pain proteomicsJ Dairy Sci20149742118213424534501
  • SullivanGMMannJJOquendoMALoESCooperTBGormanJMLow cerebrospinal fluid transthyretin levels in depression: correlations with suicidal ideation and low serotonin functionBiol Psychiatry200660550050616487493
  • HuangJTLewekeFMOxleyDDisease biomarkers in cerebrospinal fluid of patients with first-onset psychosisPLoS Med2006311e42817090210
  • MaetzlerWTianYBaurSMSerum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementiaPLoS One2012710e4804223133543
  • StrekalovaHBuhmannCKleeneRElevated levels of neural recognition molecule L1 in the cerebrospinal fluid of patients with Alzheimer disease and other dementia syndromesNeurobiol Aging20062711916298234
  • WeledjiEPAssobJCThe ubiquitous neural cell adhesion molecule (N-CAM)Ann Med Surg (Lond)201433778125568792
  • SakaiAAsadaMSenoNSuzukiHInvolvement of neural cell adhesion molecule signaling in glial cell line-derived neurotrophic factor-induced analgesia in a rat model of neuropathic painPain2008137237838817967506
  • GnanapavanSGrantDIlles-TothELakdawalaNKeirGGiovannoniGNeural cell adhesion molecule – description of a CSF ELISA method and evidence of reduced levels in selected neurological disordersJ Neuroimmunol20102251–211812220605643
  • JorgensenOSNeural cell adhesion molecule (NCAM) and prealbumin in cerebrospinal fluid from depressed patientsActa Psychiatr Scand Suppl198834529373067538
  • DaniloffJKLeviGGrumetMRiegerFEdelmanGMAltered expression of neuronal cell adhesion molecules induced by nerve injury and repairJ Cell Biol198610339299452427528
  • TzengSFChengHLeeYSWuJPHofferBJKuoJSExpression of neural cell adhesion molecule in spinal cords following a complete transectionLife Sci20016891005101211212863
  • AbrahamJDCalvayrac-PawlowskiSCoboSCombined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between Alzheimer’s disease and other dementiasBiomarkers201116216117121323605
  • Tombran-TinkJBarnstableCJPEDF: a multifaceted neurotrophic factorNat Rev Neurosci20034862863612894238
  • CrawordSEFitchevPVeliceasaDVolpertOVThe many facets of PEDF in drug discovery and disease: a diamond in the rough or split personality disorder?Expert Opin Drug Discov20138776979223642051
  • BaraniukJNCasadoBMaibachHClauwDJPannellLKHessSSA Chronic Fatigue Syndrome – related proteome in human cerebrospinal fluidBMC Neurol200552216321154
  • AmanoSYamagishiSInagakiYPigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytesMicrovasc Res2005691–2455515797260
  • PraissmanJLLiveDHWangSB4GAT1 is the priming enzyme for the LARGE-dependent functional glycosylation of alpha-dystroglycanElife20143e03943
  • BuysseKRiemersmaMPowellGMissense mutations in beta-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndromeHum Mol Genet20132291746175423359570
  • KingwellBANitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular diseaseFASEB J200014121685169610973917
  • AkyolOZorogluSSArmutcuFSahinSGurelANitric oxide as a physiopathological factor in neuropsychiatric disordersIn Vivo200418337739015341194
  • LarsonAAGiovengoSLRussellIJMichalekJEChanges in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathwaysPain200087220121110924813
  • RussellIJMichalekJEFlechasJDAbrahamGETreatment of fibromyalgia syndrome with Super Malic: a randomized, double blind, placebo controlled, crossover pilot studyJ Rheumatol19952259539588587088
  • HaradaSMatsuuraWTakanoMTokuyamaSProteomic profiling in the spinal cord and sciatic nerve in a global cerebral ischemia-induced mechanical allodynia mouse modelBiol Pharm Bull201639223023826830482
  • HeywoodWEGalimbertiDBlissEIdentification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assayMol Neurodegener2015106426627638
  • AhnVEChuMLChoiHJTranDAboAWeisWIStructural basis of Wnt signaling inhibition by Dickkopf binding to LRP5/6Dev Cell201121586287322000856
  • BrugginkKAKuiperijHBGloerichJDickkopf-related protein 3 is a potential Abeta-associated protein in Alzheimer’s DiseaseJ Neurochem201513461152116226119087
  • KroksveenACGuldbrandsenAVedelerCMyhrKMOpsahlJABervenFSCerebrospinal fluid proteome comparison between multiple sclerosis patients and controlsActa Neurol Scand20121269096
  • WalkerAKKavelaarsAHeijnenCJDantzerRNeuroinflammation and comorbidity of pain and depressionPharmacol Rev20146618010124335193
  • KosekEAltawilRKadetoffDEvidence of different mediators of central inflammation in dysfunctional and inflammatory pain – interleukin-8 in fibromyalgia and interleukin-1 beta in rheumatoid arthritisJ Neuroimmunol2015280495525773155
  • OlaussonPGerdleBGhafouriNLarssonBGhafouriBIdentification of proteins from interstitium of trapezius muscle in women with chronic myalgia using microdialysis in combination with proteomicsPLoS One2012712e5256023300707
  • OlaussonPGerdleBGhafouriNSjöströmDBlixtEGhafouriBProtein alterations in women with chronic widespread pain – an explorative proteomic study of the trapezius muscleSci Rep201551189426150212
  • González-MarreroICastañeyra-RuizLGonzález-ToledoJMHigh blood pressure effects on the blood to cerebrospinal fluid barrier and cerebrospinal fluid protein composition: a two-dimensional electrophoresis study in spontaneously hypertensive ratsInt J Hypertens2013201316465323401751